Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer Inc. buy shadow

Start price
€31.40
18.11.20
Target price
-
Performance (%)
0.64%
Price
€31.60
12:21
This prediction is currently active. Since the start of the prediction for Pfizer Inc. the price has only changed by 0.64%. This prediction currently runs until 2021-11-18. The prediction end date can be changed by shadow at any time.

According to shadow what are the pros and cons of Pfizer Inc. for the foreseeable future?

Pros
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Growths faster than the competition
Top 10 in its market
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Medium risks for its business
Small cyclical dependencies
Cons
Low dividend yield expected
Few uniques
Sustainability is little important
high free float

Comments by shadow for this prediction

In the thread Pfizer Inc. diskutieren

Buy Pfizer Inc.